Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
about
Effect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.Ruthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity.Bis-picolinamide Ruthenium(III) Dihalide Complexes: Dichloride-to-Diiodide Exchange Generates Single trans Isomers with High Potency and Cancer Cell Selectivity.Anticancer Organometallic Osmium(II)-p-cymene Complexes.Antioxidant enzyme inhibitor role of phosphine metal complexes in lung and leukemia cell lines.Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells.A comparative DFT study on aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes.Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes.Designing organometallic compounds for catalysis and therapy.Fine tuning through valence bond tautomerization of ancillary ligands in ruthenium(ii) arene complexes for better anticancer activity and enzyme inhibition properties.Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.Peptide-mediated vectorization of metal complexes: conjugation strategies and biomedical applications.Cytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosis.Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexes.The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(ii) arene anticancer complexes
P2860
Q33864513-A8E6BC49-AC3B-4918-8E70-9EE6029FF436Q34498243-FAC95A2E-44F2-414A-B664-8B31664583BEQ36287265-E905E4B6-D062-480F-9082-3D2453AB58CAQ38851401-0CF2CA6E-F919-4B8B-AD41-6868B0173A6EQ38917659-CF669864-C348-465C-843B-A6CD1000EAD6Q39011714-3B70B604-09C9-4B2D-A6B7-758DC5ED908FQ39011794-F5213C20-9C70-42D2-99A6-DA1F03B4A64FQ39095894-047AC89E-D9E4-4470-BDCD-C72ABB153AF9Q39111261-CF009D85-CDBA-4C09-8596-02D3FDCF2AB5Q39315447-2E6327F6-D1F7-4625-A468-3B024B3E85A9Q39485992-7CF6C30C-58B8-4239-8BB2-1B77D14B6EAEQ41916555-C4E02341-6F4B-42BF-A67D-01EB6B2D9DA8Q42555974-4CB1836C-B9BF-47FA-A905-23A5C83A4812Q48007506-BAA2A52C-691C-4003-BC94-9A91D8A809A5Q48211163-8945838C-9D02-4853-868C-DDFABEAC3FB7Q48235861-00A6753C-8B5A-48D2-AA4A-26FF6B208DEBQ49687144-A615108E-8B5F-419D-81E2-F29AA64952A2Q50860069-FD7517CE-5A83-4CEA-A7BB-C3BF6ACC2136Q52815276-9E35389D-D32E-4717-97F6-45C1F14BB065Q52842530-78A5C1C9-72CE-4300-B082-AECB955665A4Q52872859-1C46F37A-6A0E-4FC7-B7D5-364D7D4C3C0AQ56058410-481CE748-2A94-4683-B4A1-A5B06E0A982F
P2860
Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Amide linkage isomerism as an ...... uthenium anticancer complexes.
@en
Amide linkage isomerism as an ...... uthenium anticancer complexes.
@nl
type
label
Amide linkage isomerism as an ...... uthenium anticancer complexes.
@en
Amide linkage isomerism as an ...... uthenium anticancer complexes.
@nl
prefLabel
Amide linkage isomerism as an ...... uthenium anticancer complexes.
@en
Amide linkage isomerism as an ...... uthenium anticancer complexes.
@nl
P2093
P356
P1476
Amide linkage isomerism as an ...... ruthenium anticancer complexes
@en
P2093
Andrew J Hebden
Guy J Clarkson
Patrick C McGowan
Peter J Sadler
Simon Parsons
Thakshila Amaresekera
P304
P356
10.1021/JM900731J
P407
P577
2009-12-01T00:00:00Z